GTR 114741877
Bids Are Invited For Durvalumab 120Mg/2.4Ml And Others
ICB — International Competitive Bid
Closes Jul 23, 2026
South America
Tender Information
GTR Reference
114741877
Tendering Authority
Subscribe to view
Tender No
452/2026
Financer Name
Self-Funded
Work Title
Bids Are Invited For Durvalumab 120Mg/2.4Ml And Others
Bid Type
ICB — International Competitive Bid
Country
Subscribe to view
Geographical Region
South America
Political Region
BRIC,G20
Last Date of Bid Submission
23-07-2026
Work Detail
Durvalumab, Concentration:50 Mg/Ml, Pharmaceutical Form:Injectable Solution, Tezepelumab - Additional Features: Prefilled Syringe; Concentration: 110 Mg/Ml; Pharmaceutical Form: Injectable Solution, Triamcinolone, Composition: Hexacetonide Salt, Concentration: 20 Mg/Ml, Pharmaceutical Form: Injectable Suspension
Key Value
Tender Value
2,255,318 - BRL
Tender Documents
Global Tender Document
fcec074c-7491-4681-84a5-797579c63cb2.html
Attachments
Additional Details Available on Click
- Tendering Authority
- Publication Document (Tender Document / Tender Notice)
Disclaimer
We take all possible care for accurate & authentic tender information. However, users are requested to refer to the original Tender Notice / Tender Document published by the Tender Issuing Agency before taking any decision regarding this tender.